DARE
Price
$2.03
Change
+$0.01 (+0.50%)
Updated
Sep 2 closing price
Capitalization
27.36M
PHIO
Price
$2.12
Change
+$0.15 (+7.61%)
Updated
Sep 2 closing price
Capitalization
12.14M
Interact to see
Advertisement

DARE vs PHIO

Header iconDARE vs PHIO Comparison
Open Charts DARE vs PHIOBanner chart's image
Dare Bioscience
Price$2.03
Change+$0.01 (+0.50%)
Volume$79.04K
Capitalization27.36M
Phio Pharmaceuticals
Price$2.12
Change+$0.15 (+7.61%)
Volume$445.34K
Capitalization12.14M
DARE vs PHIO Comparison Chart in %
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. PHIO commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a StrongBuy and PHIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (DARE: $2.02 vs. PHIO: $1.97)
Brand notoriety: DARE and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 10% vs. PHIO: 3%
Market capitalization -- DARE: $27.36M vs. PHIO: $12.14M
DARE [@Biotechnology] is valued at $27.36M. PHIO’s [@Biotechnology] market capitalization is $12.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, PHIO is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 5 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • DARE’s TA Score: 5 bullish, 3 bearish.
  • PHIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DARE is a better buy in the short-term than PHIO.

Price Growth

DARE (@Biotechnology) experienced а -4.72% price change this week, while PHIO (@Biotechnology) price change was -5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DARE($27.4M) has a higher market cap than PHIO($12.1M). DARE has higher P/E ratio than PHIO: DARE (0.10) vs PHIO (0.01). PHIO YTD gains are higher at: 9.444 vs. DARE (-35.256). PHIO has higher annual earnings (EBITDA): -7.45M vs. DARE (-17.84M). PHIO has more cash in the bank: 10.8M vs. DARE (5.04M). PHIO has less debt than DARE: PHIO (0) vs DARE (3.03M). PHIO has higher revenues than DARE: PHIO (0) vs DARE (-17.7K).
DAREPHIODARE / PHIO
Capitalization27.4M12.1M226%
EBITDA-17.84M-7.45M240%
Gain YTD-35.2569.444-373%
P/E Ratio0.100.01817%
Revenue-17.7K0-
Total Cash5.04M10.8M47%
Total Debt3.03M0-
FUNDAMENTALS RATINGS
DARE vs PHIO: Fundamental Ratings
DARE
PHIO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9162
P/E GROWTH RATING
1..100
8063
SEASONALITY SCORE
1..100
5028

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (54) in the Biotechnology industry is in the same range as DARE (80). This means that PHIO’s stock grew similarly to DARE’s over the last 12 months.

PHIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DARE (100). This means that PHIO’s stock grew similarly to DARE’s over the last 12 months.

PHIO's SMR Rating (99) in the Biotechnology industry is in the same range as DARE (100). This means that PHIO’s stock grew similarly to DARE’s over the last 12 months.

PHIO's Price Growth Rating (62) in the Biotechnology industry is in the same range as DARE (91). This means that PHIO’s stock grew similarly to DARE’s over the last 12 months.

PHIO's P/E Growth Rating (63) in the Biotechnology industry is in the same range as DARE (80). This means that PHIO’s stock grew similarly to DARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DAREPHIO
RSI
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
84%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLX2.540.07
+2.83%
RLX Technology
MSIF14.170.19
+1.36%
MSC Income Fund Inc.
CYBR453.260.09
+0.02%
CyberArk Software Ltd
PROF4.47-0.06
-1.32%
Profound Medical Corp
MBIO1.51-0.03
-2.27%
Mustang Bio Inc

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with CLNN. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
-0.25%
CLNN - DARE
88%
Closely correlated
-1.66%
PHIO - DARE
81%
Closely correlated
-0.51%
AZTR - DARE
78%
Closely correlated
+9.18%
FGHQF - DARE
45%
Loosely correlated
N/A
MNMD - DARE
44%
Loosely correlated
-9.20%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been closely correlated with RIGL. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if PHIO jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-0.51%
RIGL - PHIO
84%
Closely correlated
-1.17%
CLNN - PHIO
83%
Closely correlated
-1.66%
DARE - PHIO
81%
Closely correlated
-0.25%
IMRN - PHIO
71%
Closely correlated
+0.55%
TPST - PHIO
51%
Loosely correlated
+0.71%
More